SUSAN MANSOURIAN

Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SANTA BARBARA, CA NPI 1538680707

General Payments — all program years on this page

$1,516.34

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 48
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $512.75 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $512.7518

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $172.162
ABBVIE INC. $147.737
NOVARTIS PHARMACEUTICALS CORPORATION $87.934
GlaxoSmithKline, LLC. $62.253
PFIZER INC. $23.231
Acerta Pharma LLC $19.451

By program year

Program yearAmountRecords
2022 $200.017
2023 $803.5823
2024 $512.7518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087124318 Novartis Pharmaceuticals Corporation $19.12 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087124332 Novartis Pharmaceuticals Corporation $21.26 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087124334 Novartis Pharmaceuticals Corporation $23.07 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087124344 Novartis Pharmaceuticals Corporation $24.48 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104224121 AstraZeneca Pharmaceuticals LP $19.45 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961070 ABBVIE INC. $24.33 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961072 ABBVIE INC. $17.34 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961074 ABBVIE INC. $20.46 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961076 ABBVIE INC. $15.97 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961078 ABBVIE INC. $23.93 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961080 ABBVIE INC. $19.11 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104961082 ABBVIE INC. $26.59 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115855537 GlaxoSmithKline, LLC. $18.70 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115901298 Amgen Inc. $150.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116343470 GlaxoSmithKline, LLC. $24.85 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116726104 GlaxoSmithKline, LLC. $18.70 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117619348 Amgen Inc. $22.16 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131870965 PFIZER INC. $23.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.